MoonLake Immunotherapeutics MLTX
NASDAQ MLTX
$11.41 -0.06 (-0.52%)
At close: Oct 2, 2026 · 4:00 PM EDT

MoonLake Immunotherapeutics (MLTX) Total Debt (2020 - 2022)

Updated

MoonLake Immunotherapeutics (MLTX) reported Total Debt of $150,000 for Q1 2022, down 99.0% from the prior quarter.

Analysis

MoonLake Immunotherapeutics (MLTX) Total Debt (2020 - 2022) Analysis & Trends

At the end of FY2021, MoonLake Immunotherapeutics posted Total Debt of $15 million.

  • By year, Total Debt came in at $58,063 in FY2020.
  • The Q1 2022 figure ranks as the lowest quarterly Total Debt since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 49.04 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 70.82 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 37.49 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -111.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 26.25 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 63.19 Bn
10 MoonLake Immunotherapeutics 976.17 Mn -693.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 150,000.00
Dec 31, 2021 15.00 Mn
Dec 31, 2020 58,063.00
API Access

MoonLake Immunotherapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=MLTX&period=max&api_key=YOUR_API_KEY